Parathyroid Hormone in the Pathophysiology of Osteoporosis

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

While parathyroid hormone (PTH) excess syndromes are clearly associated with bone loss, the issue of whether physiological changes in PTH secretion following the menopause or with aging also contribute to the pathogenesis of osteoporosis is somewhat unclear and the focus of considerable attention. In the early postmenopausal period, PTH appears to be responding to the estrogen deficiency-induced changes in bone turnover rather than driving these changes. PTH levels do, however, increase with age in women and in men, primarily after the age of 70 years. This secondary hyperparathyroidism of aging is associated with increased bone turnover, particularly in women, and with rates of bone loss in elderly individuals. Given the evidence that PTH can increase cortical porosity, the observation that cortical porosity increases markedly with age has led to the speculation that age-related increased PTH secretion may be responsible for this increase in cortical porosity. However, further studies are needed to better define the contribution of increased PTH concentrations towards bone loss in the elderly, particularly age-related changes in cortical bone.

Original languageEnglish (US)
Title of host publicationThe Parathyroids: Basic and Clinical Concepts: Third Edition
PublisherElsevier Inc.
Pages827-835
Number of pages9
ISBN (Print)9780123971661
DOIs
StatePublished - Sep 5 2014

Fingerprint

Parathyroid Hormone
Osteoporosis
Porosity
Bone Remodeling
Bone and Bones
Postmenopause
Secondary Hyperparathyroidism
Menopause
Estrogens

Keywords

  • Aging
  • Cortical bone
  • Fractures
  • Menopause
  • Osteoporosis
  • Trabecular bone

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Khosla, S. (2014). Parathyroid Hormone in the Pathophysiology of Osteoporosis. In The Parathyroids: Basic and Clinical Concepts: Third Edition (pp. 827-835). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-397166-1.00058-8

Parathyroid Hormone in the Pathophysiology of Osteoporosis. / Khosla, Sundeep.

The Parathyroids: Basic and Clinical Concepts: Third Edition. Elsevier Inc., 2014. p. 827-835.

Research output: Chapter in Book/Report/Conference proceedingChapter

Khosla, S 2014, Parathyroid Hormone in the Pathophysiology of Osteoporosis. in The Parathyroids: Basic and Clinical Concepts: Third Edition. Elsevier Inc., pp. 827-835. https://doi.org/10.1016/B978-0-12-397166-1.00058-8
Khosla S. Parathyroid Hormone in the Pathophysiology of Osteoporosis. In The Parathyroids: Basic and Clinical Concepts: Third Edition. Elsevier Inc. 2014. p. 827-835 https://doi.org/10.1016/B978-0-12-397166-1.00058-8
Khosla, Sundeep. / Parathyroid Hormone in the Pathophysiology of Osteoporosis. The Parathyroids: Basic and Clinical Concepts: Third Edition. Elsevier Inc., 2014. pp. 827-835
@inbook{3a4c1ffd86354e6bba233a138e6121dd,
title = "Parathyroid Hormone in the Pathophysiology of Osteoporosis",
abstract = "While parathyroid hormone (PTH) excess syndromes are clearly associated with bone loss, the issue of whether physiological changes in PTH secretion following the menopause or with aging also contribute to the pathogenesis of osteoporosis is somewhat unclear and the focus of considerable attention. In the early postmenopausal period, PTH appears to be responding to the estrogen deficiency-induced changes in bone turnover rather than driving these changes. PTH levels do, however, increase with age in women and in men, primarily after the age of 70 years. This secondary hyperparathyroidism of aging is associated with increased bone turnover, particularly in women, and with rates of bone loss in elderly individuals. Given the evidence that PTH can increase cortical porosity, the observation that cortical porosity increases markedly with age has led to the speculation that age-related increased PTH secretion may be responsible for this increase in cortical porosity. However, further studies are needed to better define the contribution of increased PTH concentrations towards bone loss in the elderly, particularly age-related changes in cortical bone.",
keywords = "Aging, Cortical bone, Fractures, Menopause, Osteoporosis, Trabecular bone",
author = "Sundeep Khosla",
year = "2014",
month = "9",
day = "5",
doi = "10.1016/B978-0-12-397166-1.00058-8",
language = "English (US)",
isbn = "9780123971661",
pages = "827--835",
booktitle = "The Parathyroids: Basic and Clinical Concepts: Third Edition",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Parathyroid Hormone in the Pathophysiology of Osteoporosis

AU - Khosla, Sundeep

PY - 2014/9/5

Y1 - 2014/9/5

N2 - While parathyroid hormone (PTH) excess syndromes are clearly associated with bone loss, the issue of whether physiological changes in PTH secretion following the menopause or with aging also contribute to the pathogenesis of osteoporosis is somewhat unclear and the focus of considerable attention. In the early postmenopausal period, PTH appears to be responding to the estrogen deficiency-induced changes in bone turnover rather than driving these changes. PTH levels do, however, increase with age in women and in men, primarily after the age of 70 years. This secondary hyperparathyroidism of aging is associated with increased bone turnover, particularly in women, and with rates of bone loss in elderly individuals. Given the evidence that PTH can increase cortical porosity, the observation that cortical porosity increases markedly with age has led to the speculation that age-related increased PTH secretion may be responsible for this increase in cortical porosity. However, further studies are needed to better define the contribution of increased PTH concentrations towards bone loss in the elderly, particularly age-related changes in cortical bone.

AB - While parathyroid hormone (PTH) excess syndromes are clearly associated with bone loss, the issue of whether physiological changes in PTH secretion following the menopause or with aging also contribute to the pathogenesis of osteoporosis is somewhat unclear and the focus of considerable attention. In the early postmenopausal period, PTH appears to be responding to the estrogen deficiency-induced changes in bone turnover rather than driving these changes. PTH levels do, however, increase with age in women and in men, primarily after the age of 70 years. This secondary hyperparathyroidism of aging is associated with increased bone turnover, particularly in women, and with rates of bone loss in elderly individuals. Given the evidence that PTH can increase cortical porosity, the observation that cortical porosity increases markedly with age has led to the speculation that age-related increased PTH secretion may be responsible for this increase in cortical porosity. However, further studies are needed to better define the contribution of increased PTH concentrations towards bone loss in the elderly, particularly age-related changes in cortical bone.

KW - Aging

KW - Cortical bone

KW - Fractures

KW - Menopause

KW - Osteoporosis

KW - Trabecular bone

UR - http://www.scopus.com/inward/record.url?scp=84942739504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942739504&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-397166-1.00058-8

DO - 10.1016/B978-0-12-397166-1.00058-8

M3 - Chapter

AN - SCOPUS:84942739504

SN - 9780123971661

SP - 827

EP - 835

BT - The Parathyroids: Basic and Clinical Concepts: Third Edition

PB - Elsevier Inc.

ER -